Printer Friendly
The Free Library
22,728,960 articles and books

Browse Biotechnology industries topic

Finance subtopic

 

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Tiger Group Accepting Sealed Bid Offers For Assets Of DermaSilk Manufacturer Biotech Int'l. Feb 10, 2014 525
Colorado BioScience Association Commends the State of Colorado for Granting $3.135 Million to Advance Bioscience Research from Bench to Marketplace. Nov 21, 2013 935
United States : CUREMARK LLC raises $18.5 million in common equity financing to complete NDA for autism drug. Oct 19, 2013 154
AxioMx Inc. Raises $2 Million in Second Round of Financing. Oct 8, 2013 867
Elcelyx Therapeutics completes $20 million Series C financing. Brief article Apr 1, 2013 139
Heart Genomics Receives Loan Funding from Institute for Commercialization of Public Research. Feb 8, 2013 586
Invictus Foundation(TM) Receives Grant from Genentech, a Member of the Roche Group. Jan 23, 2013 641
Solazyme Bunge Renewable Oils Joint Venture Receives Funding Approval from Brazilian Development Bank. Jan 17, 2013 1089
Canada : Versartis closes $25 million series C financing. Jan 16, 2013 344
ADMA Biologics Secures Up To $6 Million Term Loan Commitment To Advance Phase III Study. Jan 7, 2013 761
23andMe Raises More Than $50 Million in New Financing. Dec 11, 2012 550
AGTC Secures $37.5M Series B Funding. Nov 19, 2012 883
Compugen Announces $15 Million Funding Agreement for Its Keddem Subsidiary. Nov 19, 2012 1138
Ziarco Secures Series A Funding. Nov 5, 2012 811
Tolera Therapeutics closes Series B-3 financing, raises $5.5 million to submit Phase 3 Special Protocol Assessment for its immune targeting biologic drug in kidney transplantation. Oct 16, 2012 491
RXi Pharmaceuticals Awarded NCI SBIR Funding to Advance Self-Delivering RNAi Technology. Oct 4, 2012 896
HemoShear Closes a $1MM Debt Financing Round to Support Continued Expansion. Sep 26, 2012 618
Austria : Arsanis expands its anti-infective monoclonal antibody programs with additional grant support from FFG and EUROSTARS. Sep 11, 2012 364
Arsanis Expands Its Anti-Infective Monoclonal Antibody Programs with Additional Grant Support from FFG and EUROSTARS. Sep 10, 2012 642
United States : CORONADO BIOSCIENCES gets US $15 million secured loan facility. Brief article Sep 2, 2012 128
Global MSL Team Budgets Top $30 Million, Finds Cutting Edge Information. Aug 15, 2012 452
GE Capital is Administrative Agent on $100 Million Senior Credit Facility for Affymetrix, Inc. Jul 9, 2012 400
Do investors care about earnings management? Latif, Saira; Yang, Yi Report Jun 22, 2012 5239
Taiwan Medtech fund may fail to complete fund raising. Liu, Philip Jun 12, 2012 380
PhaseBio Pharmaceuticals Received an Additional $23 Million With Completion of the Third Tranche of a Series B Financing For Advancement of Metabolic and Cardiovascular Product Portfolio. Jun 5, 2012 540
Profectus BioSciences, Inc. Receives $5.6M Grant to Develop a Vaccine to Protect Humans against Infection with Nipah/Hendra Viruses. May 9, 2012 1094
Profectus BioSciences Receives NIAID Grant to Develop a Vesicular Stomatitis Virus-vectored Vaccine for Ebola and Marburg Viruses. May 2, 2012 904
LabCorp[R] Enters into New Credit Facility Totaling $1.0 Billion. Dec 21, 2011 572
Aviir Announces Agreement to Raise up to $30 Million in Latest Financing Round. Dec 20, 2011 815
Profectus BioSciences, Inc. Receives $5.4M Grant to Develop a Monocolonal Antibody Against Infection by Nipah/Hendra Viruses. Dec 13, 2011 769
Amarantus BioSciences Receives Grant from Brewer Sports International for Traumatic Brain Injury. Nov 30, 2011 900
Prolacta Bioscience[R] Secures Series D Funding from Health Evolution Partners. Nov 3, 2011 1083
Semprus BioSciences receives million-dollar grant to develop bacteria-resistant trauma implants. Nov 1, 2011 603
Arsanis Receives Grant from the Austrian Research Promotion Agency for Pre-Clinical and Clinical Development of Monoclonal Antibodies Against Severe Nosocomial Infections. Oct 19, 2011 505
Arteaus Therapeutics, LLC Raises $18M to Prevent Migraines. Oct 19, 2011 913
Cutting Edge Information Finds Country-Level Medical Affairs Budgets Now Average $1.9 Million. Oct 13, 2011 452
Pharmaceutical Competitive Intelligence Budgets Grow 62%. Oct 11, 2011 458
AGTC Receives Grant from the Foundation Fighting Blindness for Pre-Clinical Study of Gene Therapy for Eye Disease. Sep 21, 2011 912
Investigator Initiated Trial Budgets up 21%, Finds New Study. Sep 13, 2011 460
Diamyd Medical: Diamyd Awarded Three Million Dollar Grant and Expands the NTTDS Portfolio. Sep 12, 2011 1105
TMF will raise NT$5 b. fund by year end. Liu, Philip Aug 17, 2011 316
Redwood Bioscience Secures Funding for Optimized Conjugate Drug Development. Jun 27, 2011 900
Sequenom Enters Into New $30.0 Million Credit Facility. Jun 2, 2011 1127
Burrill & Co. pledges US$30m. investment in Taiwan's biotech industry. Liu, Ken May 31, 2011 283
Ma designates biotech as Taiwan's next pivotal industry. Liu, Ken Brief article May 19, 2011 250
ACADIA Pharmaceuticals Awarded Grant from National Institutes of Health for the Development of Novel ER-beta Agonists. May 17, 2011 851
RXi Pharmaceuticals and the University of Massachusetts Medical School Announce Massachusetts Life Sciences Center Cooperative Research Grant for RNAi Therapeutics for ALS. Apr 28, 2011 1209
4 Small Businesses Awarded Scholarships to Attend International Biotechnology Convention, Other Funds Still Available. Apr 25, 2011 622
KellBenx Secures $2.5 Million Funding Round. Apr 21, 2011 343
Aerie Pharmaceuticals Completes $30 Million Series B Financing to Fund Further Development of Innovative Glaucoma Product Portfolio. Mar 7, 2011 1243
GE Capital Provides $12.5 Million Senior Secured Multi-Draw Term Loan Facility to Oncothyreon Inc. Feb 10, 2011 390
Commonwealth Biotechnologies, Inc. Announces Filing for Reorganization Under Chapter 11 Bankruptcy. Jan 21, 2011 373
MabCure Secures $10 Million Funding Commitment from an Institutional Investor Managed by Roswell Capital Partners. Jan 20, 2011 668
DBV Technologies closes $25.5 ([euro]19,4) million Series 'C' financing round including new investors InnoBio, Lundbeckfond Ventures, Shire plc, and ALTO Invest; as well as existing investors Sofinnova Partners and ALK Abello. Jan 5, 2011 891
Advanced Cell Technology Secures $25 Million Funding Commitment. Dec 31, 2010 802
Longwood Launches First Fund. Company overview Dec 27, 2010 498
'New' lenders ante up $175M for lab loan. Dec 8, 2010 258
Funds shortfall stymies biotech incubator plan. Dec 1, 2010 416
Agenta Receives $1.1 Million NIH-SBIR Grant to Develop Novel Skin Healing and Regeneration Technology. Nov 11, 2010 506
Northwest Biotherapeutics Receives Two 'Qualified Therapeutic Discovery Project' Grants. Nov 4, 2010 903
ImmunoCellular Therapeutics Receives $244,479 Grant Under the Patent Protection and Affordable Care Program. Nov 4, 2010 650
Bio-Path Holdings Awarded Grant from the U.S. Government's Qualifying Therapeutic Discovery Project Program. Nov 3, 2010 669
Emergent BioSolutions Receives Loan Repayment from Protein Sciences Corporation. Nov 3, 2010 162
Expression Analysis and Illumina Fund GWAS and Data Analysis Grant Program to Support Cancer Research. Nov 2, 2010 724
Benitec Limited (ASX:BLT) Cash Flow Update For The Quarter Ended 30 September 2010. Oct 29, 2010 305
NOXXON Confirms Total Capital Raise of [euro]35m. Oct 12, 2010 410
Q Chip raises pounds 2m in funding round to boost production. Sep 16, 2010 284
AGTC Receives Second Grant from Food and Drug Administration for Clinical Study of Genetic Respiratory Disease. Clinical report Sep 16, 2010 771
AGTC Receives Grant from Food and Drug Administration for Clinical Study of Genetic Retinal Disease. Clinical report Sep 13, 2010 860
Taligen Closes $10 Million Series B Financing Tranche. Aug 23, 2010 368
HemaQuest Pharmaceuticals Raises Additional $4M to Bring Total to $16M in Series B Financing. Jul 28, 2010 457
United States : Chiasma collects $2M in debt financing. Jul 25, 2010 180
Belgian Ablynx gets R&D funding. Jul 6, 2010 115
Expert urges gov't to step up formation of NT$60b. biotech fund. Liu, Philip Jul 5, 2010 389
Creative financing: the SEDA, a financial "bridge" for biotechs. Nowak, Mike Report Jul 1, 2010 1746
Biotechnology company Exelixis Inc (South San Francisco CA) said Thursday it entered two financing deals for a combined $160 million. Jun 7, 2010 152
Exelixis to Raise $160 Million through Financing Transactions with Silicon Valley Bank and Deerfield Management. Jun 3, 2010 974
Biotech company nets vital funding. Jun 3, 2010 367
PolyMedix Receives National Science Foundation Grant to Support Development of Antimicrobial Sutures. May 27, 2010 865
NOXXON Pharma AG raises [euro]33 million in Series D Round. May 27, 2010 1088
Phage Pharmaceuticals Launched -- Receives Funding for Purchase of Assets. May 24, 2010 473
BIO Asks Congress to Fund GREEN JOB Act. May 18, 2010 781
Viral Genetics Opens Lab in Texas: Lead Scientist Awarded $750,000 Grant. Apr 19, 2010 1018
SiDMAP Chief Scientist to Collaborate on Cancer Research Grant with Johns Hopkins School of Medicine. Apr 6, 2010 497
PolyMedix Secures $14 Million Credit Facility and Files Shelf Registration Statement. Apr 1, 2010 1085
Amyris Biotechnologies Secures Investment from Temasek Holdings. Mar 31, 2010 252
Multiple Myeloma Research Foundation (MMRF) Grants $1.0 Million Each to Intellikine, Inc. and Tragara Pharmaceuticals, Inc. to Advance Next-Generation Therapies for Multiple Myeloma. Mar 29, 2010 843
Advanced Cell Technology's RPE Cells Granted Orphan Drug Status from FDA for Treatment of Stargardt's Macular Dystrophy. Mar 2, 2010 783
Austrian Sanochemia sends AlcaSynn into insolvency. Feb 19, 2010 140
Advaxis Closes Second Company-Run Debt Financing. Oct 28, 2009 526
TechnoVax Receives $2.9 Million Grant for Flu and Influenza Virus-Like Particle (VLP) Vaccine Program. Oct 20, 2009 371
Biotech fundraising rises amid vaccine hype, cash need. Brief article Oct 12, 2009 313
Bio-Clean International Secures $300,000 Investment. Oct 9, 2009 634
Amyris Secures Funding to Advance Scale Up, First Commercial Plant. Oct 1, 2009 823
Life Technologies Foundation Awards $1.7 Million in Grants to Advance Science. Sep 29, 2009 550
Advaxis Secures $5.0 Million Investment. Sep 25, 2009 799
An innovative financing tool for biotech: facing one of the most severe market downturns in recent decades, growing and developing biotech companies need to be creative when accessing capital. An innovative financing tool, pioneered by a US fund, has provided a useful alternative for European biotech companies to complement their financing strategies. Sep 1, 2009 1527
Tech startup of the month: company OPX Biotechnologies Inc. Peterson, Eric Aug 1, 2009 556
Israeli drug-development company BiolineRX said that Ikaria Holdings Inc (Clinton NJ) had agreed to pay $285 million for a license to develop and market its BL-1040 drug for heart attack patients. Brief article Jul 13, 2009 137
Nanogen Completes Asset Sale. Jul 8, 2009 417
Compugen Announces Additional Grants from Israel Office of Chief Scientist for Validation Studies of Therapeutic Candidates. Jun 24, 2009 607
Advaxis Completes Debt Financing. Jun 18, 2009 561
PolyMedix Receives $923,000 SBIR Grant to Support Development of LMWH Antagonists. Jun 12, 2009 747
UBS says Bristol-Myers not in talks for Elan Stake. Brief article Jun 8, 2009 167
Compugen Awarded Grants From Israel Office of Chief Scientist. Jun 3, 2009 601
PolyMedix Secures $10 Million Equity Line Facility with Dutchess Equity Fund, LP. May 20, 2009 794
Biotechnology companies struggling with funding shortages because of the global credit crisis will be scrambling later this month for the attention of cash-rich drugmakers at the world's largest annual meeting of cancer doctors. May 18, 2009 468
E&Y report says biotechs running out of funding options. May 11, 2009 341
SEQUENOM Announces Cost Cutting Initiative in Genetic Analysis Business. Apr 23, 2009 1054
Viral Genetics Successfully Secures Grant for New Lyme Research Study. Mar 18, 2009 908
Advanced Cell Technology Secures $5 Million Credit Facility to Develop RPE Program for the Treatment of Diseases of the Eye. Mar 11, 2009 1033
Multiple Myeloma Research Foundation (MMRF) Grants $1.0 Million to Aileron Therapeutics and Astex Therapeutics to Advance New Therapies for Multiple Myeloma. Mar 2, 2009 805
Heptares Therapeutics Ltd., a two-year-old British biotech company, has raised 21 million pounds ($30.6 million) in private equity finance from Swiss drug giant Novartis AG and two venture capital firms. Brief article Mar 2, 2009 132
AC Immune SA. Brief article Feb 2, 2009 213
Hydra Biosciences Raises $22 Million in Series D Financing. Jan 16, 2009 461
Biotechnology could lose 100 public companies in 2009. Jan 12, 2009 356
INNEXUS BIOTECHNOLOGY GETS PATENT GRANTS IN EUROPE. Dec 1, 2008 300
Financing Sector: the global economic crisis has cut funding for biotechnology companies to the lowest level in a decade, triggering bankruptcies and threatening development of drugs based on biomedical breakthroughs. Nov 24, 2008 329
InNexus Biotechnology Receives Patent Grants in Europe. Oct 30, 2008 477
Major cash injection for firm at forefront of Alzheimer's fight; Alzeim looking to expand production of daffodil drug. Oct 29, 2008 650
Invitrogen Completes Syndication of Financing for Applied Biosystems Acquisition. Sep 26, 2008 719
Emergent BioSolutions Initiates Lawsuit Against Protein Sciences and Its Senior Management Regarding Delayed Asset Acquisition. Jul 9, 2008 715
EpiVax Receives $600,000 Grant to develop treatment for Diabetes from National Institutes of Health. Jul 8, 2008 1079
Symphogen S/A. Brief article Jun 16, 2008 101
Instrument companies' extraordinary charges. Apr 15, 2008 1226
NOXXON Receives Research Grant from the Federal Ministry of Education and Research. Apr 7, 2008 187
Expression Pathology Obtains Maryland Funding to Develop Breast Cancer Test. Feb 7, 2008 376
Arcion Therapeutics Raises $8.8 Million "A" Round. Jan 9, 2008 591
Protagen raises 1 million [euro]. Brief article Jan 1, 2008 166
Neurologix Receives Grant from the Epilepsy Research Foundation for Gene Transfer Research. Dec 4, 2007 1181
Research and Markets: the New Generex Biotechnology Corporation Latest Product Pipeline Report Contains Contact Information, Business Summary, Company Details and Selected Financial Data. Report Nov 8, 2007 240
LEAD Therapeutics Raises $17 Million in Series A Financing. Nov 5, 2007 842
Japan. Brief article Oct 31, 2007 173
AVI BioPharma Receives Major Research and Development Grant From Charley's Fund for Duchenne Muscular Dystrophy. Oct 15, 2007 1063
Health Discovery Corporation's Private Equity Offering Oversubscribed. Oct 4, 2007 452
Panacos Secures $20 Million Debt Financing. Jun 28, 2007 562
Pluristem Receives $830,000 Grant from Israeli Government for Development of the PLX-I Stem Cell Product. May 31, 2007 651
Pluristem Closes on $13.5 Million Private Equity Investment. May 22, 2007 690
Pasteuria Bioscience Raises $5.3M in Series B. Company overview May 4, 2007 377
ECI Biotech receives small-business grant; $299,066 will aid periodontal work. Feb 13, 2007 170
Pluristem Receives $470,000 Grant from Israeli Government to Further Develop PLX-I Stem Cell Product. Aug 24, 2006 804
The bottom line: data from recent industry financial reports. Dollar amounts in millions. Statistical table Jul 31, 2006 447
Advanced Cell Technology Applauds Governor Schwarzenegger for Directing $150 Million Loan to Fund Stem Cell Research; Further Positions California as World Leader in Field of Regenerative Medicine. Jul 21, 2006 493
SFBC International Provides Update on Miami Operations; Company Also Receives Waivers for Credit Facility. Jun 29, 2006 771
Adnexus Therapeutics Closes $27M Series B Funding; Series B Financing Led by Venrock will Advance Breakthrough New Product Class, AdNectins. Jun 26, 2006 840
SFBC International Comments on Moody's Debt Ratings Action. Apr 12, 2006 724
SFBC International Granted Waivers for Credit Facility. Mar 29, 2006 776
Nabi Biopharmaceuticals granted Fast Track Designation by FDA for Civacir to prevent HCV re-infection in liver transplant patients. Rathjen, Thomas Brief Article Feb 28, 2006 194
INTEGRA LIFESCIENCES ESTABLISHES $200 MIL. CREDIT. Brief Article Feb 1, 2006 250
Lifeline Biotechnologies Reduces Debt By $250,000. Dec 7, 2005 455
U.S. Microbics Engages Oaktree Ventures, Inc. for Capital Formation; Funds for Mexico Operations and Agricultural Growth Products. Dec 2, 2005 447
Vital Therapies Completes First Closing of $8 Million Private Equity Financing. Nov 1, 2005 823
US Government $20M NIAID Grant Funds Proteome Systems' ''Catalytic Scavenger Compounds'' to Treat Radiation Damage in Humans Caused by Terrorist Attacks or Industrial Accidents; PSL Invited to Present at Prestigious BIO Investor Forum. Oct 20, 2005 650
Aerie Pharmaceuticals Announces $21 Million Series A Financing; Company to Develop Innovative Products for Treatment of Glaucoma. Oct 12, 2005 881
GenPat77 Receives BMBF Grant to Accelerate Development of CEACAM1 Into Clinical Trials. Oct 11, 2005 463
Hercules Provides $7.5M Financing to Predicant Biosciences. Oct 11, 2005 496
VIRxSYS Completes $30 Million Financing. Oct 11, 2005 817
Bolder BioTechnology Awarded NIH Phase I SBIR Grant to Develop Bioscavenger Protein for Detoxifying Nerve Agents. Oct 10, 2005 334
Serenex Raises $30 Million in Series C Financing. Oct 6, 2005 699
Minotaur awarded SBTT Grant. Brief Article Jul 4, 2005 155
Human Genome Sciences receives milestone payments from GlaxoSmithKline for GSK716155 progress. Jul 1, 2005 366
CRUCELL REPORTS 2004 THREE-FOLD INCREASE OVER 2003 REVENUE. Mar 1, 2005 2190
Life support: the network helping to boost Indiana's life-sciences industry. Kaelble, Steve Jan 1, 2005 1341
Biotechnology. Brief Article Dec 15, 2004 102
India. Dec 15, 2004 101
ECI BIOTECH OF WORCESTER AWARDED NATIONAL EYE INSTITUTE GRANT. Aug 1, 2004 2614
Monsanto sponsors GMO Swedish lager. Jul 19, 2004 863
MEDMIRA REPORTS 2ND QTR NET LOSS OF $996 THOUSAND. May 1, 2004 523
WellGen receives investment from Amphion Capital Partners. Brief Article May 1, 2004 155
Biotechnology. Brief Article Apr 30, 2004 151
Value creation in the biotechnology industry; as a recent study demonstrates, it's non-financial disclosures that are key to value creation in this and other growing industries. Understand an industry's value drivers and you'll better understand the potential of individual firms. McConomy, Bruce; Xu, Bixia Apr 1, 2004 2127
MEDIMMUNE PLANS TO ACHIEVE $2 BILLION IN REVENUES BY 2009. Apr 1, 2004 1383
BIOXEL PHARMA REPORTS NET LOSS OF $3.5 MILLION FOR 9 MONTHS. Company Profile Jan 1, 2004 1082
Life Science Sales Index: operating margins improve in Q3. Editorial Dec 15, 2003 1360
ICON REPORTS 47% INCREASE IN REVENUES FOR 1ST QTR FY 2004. Nov 1, 2003 555
PARALLELE BIOSCIENCE SECURES $22.5 MILLION IN FINANCING. Nov 1, 2003 445
GENSCI REPORTS DECREASE IN NET LOSS FOR 2ND QTR '03. Oct 1, 2003 581
PERKINELMER REPORTS 2ND QTR '03 REVENUE DOWN 2% FROM 2002. Sep 1, 2003 1109
Amersham Biosciences. Aug 31, 2003 481
Aastrom Biosciences receives NIH grant to expand development of cell-base approaches for bone regeneration. Brief Article Jul 11, 2003 239
MWG Biotech reported a 6.6% decline in sales for the first quarter to 11.4 million [euro] ($12.3 million = 0.93 [euro] = $1) (see IBO 5/31/03). (Organizational news: company announcements). Brief Article Jun 15, 2003 82
Making the case for ag biotech investment. (Investing). Steen, Tom Jun 1, 2003 751
Amersham Biosciences. Brief Article May 31, 2003 193
Life Science sales show mixed results. May 31, 2003 590
Affymetrix lowers first quarter forecast. (Executive briefing: news, trends & market intelligence for instrument executives). Brief Article Apr 15, 2003 116
HYCOR REPORTS INCREASE IN 4TH QTR AND YEAR-END PROFIT. Apr 1, 2003 477
APPLIED BIOSYSTEMS REPORTS $29.9 MILLION NET INCOME 2ND QTR. Mar 1, 2003 1216
Amersham Biosciences. Feb 28, 2003 381
January strikes sour note for stocks. Jan 31, 2003 3499
Korea. (Region Watch). Brief Article Jan 31, 2003 99
Organ Recovery Systems receives $14 million in financing from variety of previous institutional investors. Brief Article Jan 31, 2003 190
Life science and government spending lift prospects. Jan 15, 2003 1058
BioLife Solutions awarded SBIR grant from NIH. Dec 9, 2002 251
IMMUCELL RETURNS TO PROFITABILITY. Dec 1, 2002 531
IDEXX REPORTS 3RD QTR NET INCOME INCREASED 22%. Dec 1, 2002 472
The bottom line. Oct 15, 2002 434
Life sciences industry outlook. Panel Discussion Oct 1, 2002 4383
EPOCH BIOSCIENCES REPORTS INCREASED FIRST QTR. REVENUES. Brief Article Jun 1, 2002 948
EXACT SCIENCES REPORTS NET LOSS OF 7.6 MILLION FOR FIRST QTR. Brief Article Jun 1, 2002 647
Hybridon Announces Third Quarter Results. Nov 15, 2001 747
NeoTherapeutics Reports 55% Improvement in Third Quarter Financial Results. Nov 14, 2001 1545
Orchid BioSciences, Inc. Reports Third Quarter Financial Results. Nov 13, 2001 3043
ThermoGenesis Corp. Announces First Quarter Results. Nov 13, 2001 818
Maxygen Reports Strong Third Quarter 2001 Financial and Operating Results. Nov 13, 2001 1690
Genelabs Technologies, Inc. Reports Third Quarter and Nine Month 2001 Financial Results. Nov 13, 2001 1760
Orchid BioSciences, Inc. Reports Third Quarter Financial Results. Nov 8, 2001 3043
Trimeris Announces Third Quarter 2001 Results. Nov 8, 2001 903
Myriad Genetics, Inc. Reports Results for First Quarter of Fiscal 2002. Nov 7, 2001 1007
Paradigm Genetics announces Third Quarter Financial Results, Revenues Increase 77%. Nov 7, 2001 1871
Neurocrine Biosciences Reports Positive Third Quarter 2001 Results; Neurocrine Awarded SBIR Grant From NIH for GnRH Antagonist Program. Nov 1, 2001 1461
Transgenomic, Inc. Reports Record Third Quarter Revenues. Oct 31, 2001 1547
BioMarin Announces Third Quarter 2001 Financial Results. Oct 26, 2001 1139
Incyte Genomics Reports Record Revenues for Third Quarter 2001. Oct 25, 2001 2210
Human Genome Sciences Reports Financial Results for Third Quarter of 2001. Oct 25, 2001 2409
Affymetrix Reports Third Quarter Results. Oct 24, 2001 1876
Genzyme Transgenics Reports Third Quarter 2001 Financial Results. Oct 22, 2001 902
ArQule, Inc. Reports Financial Results for Third Quarter Ended September 30, 2001. Oct 18, 2001 1185
Genzyme General Reports 33 Percent Increase In Third-Quarter Revenues. Oct 18, 2001 4667
Genzyme Biosurgery Reports Continued Revenue Growth in Third Quarter. Oct 18, 2001 4113
Genzyme Molecular Oncology Reports Third Quarter 2001 Results. Oct 18, 2001 2887
Sangamo BioSciences Reports Third-Quarter Financial Results. Oct 18, 2001 1344
Millennium Reports Third Quarter 2001 Financial Results. Oct 16, 2001 2915
SFBC INTERNATIONAL SEES CONTINUED GROWTH IN SALES/EARNINGS. Brief Article Oct 1, 2001 445
Thermogenesis Corp. Announces Fiscal Year 2001 Results. Sep 27, 2001 1292
Orchid Reaffirms Third Quarter Forecasts. Sep 18, 2001 787
Genzyme Transgenics Updates Expectations and Announces September 10, 2001 Conference Call. Sep 7, 2001 440
DIACRIN REPORTS 2ND QTR NET LOSS OF $1.3 MILLION. Brief Article Sep 1, 2001 292
U. S. Microbics Reports Record-Breaking Nine Month Results. Aug 22, 2001 611
NeoTherapeutics Reports 46 Percent Improvement In Second Quarter Financial Results. Aug 14, 2001 1482
Maxygen Reports Second Quarter 2001 Financial Results. Aug 14, 2001 1145
Genelabs Technologies, Inc. Reports Second Quarter and Six Month 2001 Financial Results. Aug 13, 2001 1261
Trimeris Announces Second Quarter 2001 Results. Aug 9, 2001 845
Orchid BioSciences, Inc. Reports Second Quarter Financial Results. Aug 7, 2001 2724
TriPath Imaging Announces Agreement to Develop Molecular Cancer Diagnostics with BD. Aug 2, 2001 1827
Transgenomic, Inc. Reports Record Second Quarter Revenues. Aug 1, 2001 1473
Paradigm Genetics Announces Second Quarter Financial Results, Revenues Increase 257%. Aug 1, 2001 1578
Neurocrine Biosciences Reports Second Quarter 2001 Results; Company Expands Clinical Development Efforts. Jul 31, 2001 1669
BioMarin Announces Second Quarter 2001 Financial Results. Jul 27, 2001 1220
Invitrogen Announces Second Quarter 2001 Results And Executive and Board Changes. Jul 26, 2001 4158
Human Genome Sciences Reports Financial Results for Second Quarter of 2001. Jul 26, 2001 2993
Affymetrix Reports Second Quarter Results. Jul 25, 2001 1846
BioVentures Sees First Business Graduate. Friedman, Mark Brief Article Jul 23, 2001 165
Genzyme Transgenics Reports Second Quarter 2001 Financial Results. Jul 19, 2001 877
Genzyme General Reports 28 Percent Increase in Second-Quarter Revenues. Jul 19, 2001 5007
Genzyme Biosurgery Reports Second Quarter Results. Jul 19, 2001 4084
Genzyme Molecular Oncology Reports Second Quarter 2001 Results. Jul 19, 2001 2837
Sangamo BioSciences Reports Second-Quarter Financial Results. Jul 19, 2001 1437
Incyte Reports Financial Results for Second Quarter of Fiscal 2001 With Revenues Up 22%, Its Fifth Consecutive Quarter of Double-Digit Sales Growth. Jul 19, 2001 1342
ArQule, Inc. Reports Financial Results for Second Quarter Ended June 30, 2001. Jul 17, 2001 1191
Millennium Reports Second Quarter 2001 Financial Results. Jul 17, 2001 2785
Maxygen Announces Improved Financial Outlook. Jul 12, 2001 415
Trimeris Announces First Quarter 2001 Results. May 11, 2001 755
Maxygen Reports First Quarter 2001 Financial Results. May 8, 2001 1639
Human Genome Sciences Reports Financial Results for First Quarter of 2001. Apr 27, 2001 2135
Sangamo BioSciences Reports First-Quarter Financial Results. Apr 25, 2001 1266
Affymetrix Reports First Quarter Results. Apr 25, 2001 2346
Incyte Reports Financial Results for First Quarter of Fiscal 2001 Revenues Up 25%. Apr 25, 2001 1270
Genzyme Transgenics Reports First Quarter 2001 Financial Results. Apr 20, 2001 920
ArQule, Inc. Reports Financial Results for First Quarter Ended March 31, 2001. Apr 19, 2001 1114
Genzyme General's Revenues Increase 25 Percent in First Quarter. Apr 19, 2001 4238
Genzyme Molecular Oncology Reports First Quarter 2001 Financial Results. Apr 19, 2001 1988
ArQule, Inc. to Report First Quarter Financial Results on April 19, 2001. Apr 12, 2001 374
Millennium to Webcast Conference Call on First Quarter 2001 Financial Results on April 18, 2001. Apr 11, 2001 211
Genelabs Technologies, Inc. Reports 2000 Year End and Fourth Quarter Financial Results. Mar 29, 2001 1405
Bionova Holding Announces 2000 Year-End Results and Litigation Update. Mar 6, 2001 1082
CELERA GENOMICS REPORTS $20.3 MILLION 2ND QTR REVENUES. Brief Article Mar 1, 2001 1027
Exelixis Announces Fourth Quarter and Year End Financial Results. Feb 28, 2001 1870
Genset Reports Year End 2000 Financial Results. Feb 20, 2001 1645
Select Therapeutics Announces Second Quarter 2001 Results. Feb 15, 2001 1029
Trimeris Announces Fourth Quarter and Year-End 2000 Results. Feb 15, 2001 878
Maxygen Reports Fourth Quarter and Year End 2000 Financial Results. Feb 13, 2001 1955
MorphoSys Previews Year 2000 Revenues. Feb 8, 2001 645
Paradigm Genetics Announces Year End 2000 Financial Results, Revenue Increases 371% Over 1999. Feb 8, 2001 1720
Paradigm Genetics to Host Live Webcast of Fourth Quarter, Year-End 2000 Financial Results Conference Call. Feb 5, 2001 379
Neurocrine Biosciences Announces the Webcast of Its Year End 2000 Earnings Release And Conference Call. Feb 1, 2001 326
Incyte Reports Record Revenue of $194.2 Million for Fiscal Year 2000, Up 24% From Prior Year. Feb 1, 2001 1845
Sangamo BioSciences Reports Fourth-Quarter and Year-End Financial Results. Feb 1, 2001 1169
Millennium Reports Year End 2000 Financial Results - Provides 2001 Financial Guidance -. Jan 23, 2001 2431
Demegen Reports Fiscal Year 2000 Results. Dec 18, 2000 538
Maxygen Reports 2000 Third Quarter Financial Results. Nov 14, 2000 1601
Genelabs Technologies, Inc. Reports Third Quarter And Nine Month 2000 Financial Results. Nov 14, 2000 1108
Enchira Biotechnology Announces Third Quarter Earnings Report; Arbitration with Maxygen Commences. Nov 13, 2000 703
Maxygen to Release Third Quarter 2000 Earnings on November 14, 2000. Nov 10, 2000 245
Orchid BioSciences, Inc. Reports Third Quarter Financial Results. Nov 9, 2000 2137
Exelixis Announces Third Quarter Financial Results. Nov 8, 2000 1501
Human Genome Sciences Reports Third Quarter Financial Results. Nov 7, 2000 3220
Myriad Genetics, Inc. Reports Results for First Quarter of Fiscal 2001. Nov 2, 2000 907
Trimeris Announces Third Quarter 2000 Results. Nov 1, 2000 765
Paradigm Genetics Announces Third Quarter 2000 Financial Results, Revenue Increases 829% Over 1999. Nov 1, 2000 1530
Invitrogen Corporation Announces Third Quarter Results. Nov 1, 2000 2244
Transgenomic, Inc. Reports Record Third Quarter Revenues. Oct 31, 2000 1324
BioMarin Announces Third Quarter 2000 Financial Results. Oct 30, 2000 1839
Biomatrix Reports Third Quarter Financial Results. Oct 24, 2000 2014
Trimeris Inc. Invites You to Join Its Third Quarter Conference Call on the Web. Oct 24, 2000 247
Affymetrix Reports Profitable Quarter. Oct 24, 2000 1853
Genset Reports Third Quarter 2000 Financial Results. Oct 23, 2000 1635
Genzyme Corp. Reports Third-Quarter Financial Results For Genzyme Surgical Products. Oct 19, 2000 3341
Genzyme Corp. Announces Genzyme Molecular Oncology's Third Quarter Financial Results. Oct 19, 2000 3589
Genzyme Corp. Announces Third-Quarter Financial Results for Genzyme General. Oct 19, 2000 4785
Genzyme Transgenics Reports Third Quarter 2000 Financial Results. Oct 18, 2000 1322

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters